AAAAAA

   
Results: 1-17 |
Results: 17
Cytotoxicity of antiosteosarcoma recombinant immunotoxins composed of TP-3Fv fragments and a truncated Pseudomonas exotoxin A
Authors: Onda, M Olafsen, T Tsutsumi, Y Bruland, OS Pastan, I
Citation: M. Onda et al., Cytotoxicity of antiosteosarcoma recombinant immunotoxins composed of TP-3Fv fragments and a truncated Pseudomonas exotoxin A, J IMMUNOTH, 24(2), 2001, pp. 144-150
Synthesis, purification and biodistribution of (205)-Bi-DOTMP, visualizingbone deposition patterns with autoradiography
Authors: Hassfjell, S Ingebrigtsen, K Bruland, OS
Citation: S. Hassfjell et al., Synthesis, purification and biodistribution of (205)-Bi-DOTMP, visualizingbone deposition patterns with autoradiography, NUCL MED BI, 28(4), 2001, pp. 425-433
Radionuclide therapy with bone-seeking compounds: Monte Carlo calculationsof dose-volume histograms for bone marrow in trabecular bone
Authors: Kvinnsland, Y Skretting, A Bruland, OS
Citation: Y. Kvinnsland et al., Radionuclide therapy with bone-seeking compounds: Monte Carlo calculationsof dose-volume histograms for bone marrow in trabecular bone, PHYS MED BI, 46(4), 2001, pp. 1149-1161
Exposure of human osteosarcoma and bone marrow cells to tumour-targeted alpha-particles and gamma-irradiation: analysis of cell survival and microdosimetry
Authors: Aurlien, E Larsen, RH Akabani, G Olsen, DR Zalutsky, MR Bruland, OS
Citation: E. Aurlien et al., Exposure of human osteosarcoma and bone marrow cells to tumour-targeted alpha-particles and gamma-irradiation: analysis of cell survival and microdosimetry, INT J RAD B, 76(8), 2000, pp. 1129-1141
Interstitial fluid pressure in human osteosarcoma xenografts: Significanceof implantation site and the response to intratumoral injection of hyaluronidase
Authors: Brekken, C Bruland, OS Davies, CD
Citation: C. Brekken et al., Interstitial fluid pressure in human osteosarcoma xenografts: Significanceof implantation site and the response to intratumoral injection of hyaluronidase, ANTICANC R, 20(5B), 2000, pp. 3503-3512
Hyaluronidase-induced periodic modulation of the interstitial fluid pressure increases selective antibody uptake in human osteosarcoma xenografts
Authors: Brekken, C Hjelstuen, MH Bruland, OS Davies, CD
Citation: C. Brekken et al., Hyaluronidase-induced periodic modulation of the interstitial fluid pressure increases selective antibody uptake in human osteosarcoma xenografts, ANTICANC R, 20(5B), 2000, pp. 3513-3519
Oral presentations in science and medicine. An art in decline?
Authors: Pihl, A Bruland, OS
Citation: A. Pihl et Os. Bruland, Oral presentations in science and medicine. An art in decline?, ANTICANC R, 20(5A), 2000, pp. 2795-2799
Telemedicine in radiotherapy treatment planning: requirements and applications
Authors: Olsen, DR Bruland, OS Davis, BJ
Citation: Dr. Olsen et al., Telemedicine in radiotherapy treatment planning: requirements and applications, RADIOTH ONC, 54(3), 2000, pp. 255-259
Demonstration of highly specific toxicity of the alpha-emitting radioimmunoconjugate At-211-rituximab against non-Hodgkin"s lymphoma cells
Authors: Aurlien, E Larsen, RH Kvalheim, G Bruland, OS
Citation: E. Aurlien et al., Demonstration of highly specific toxicity of the alpha-emitting radioimmunoconjugate At-211-rituximab against non-Hodgkin"s lymphoma cells, BR J CANC, 83(10), 2000, pp. 1375-1379
Targeted radiotherapy in the treatment of osteosarcoma - Radiobiological basis, clinical status, and future prospects
Authors: Bruland, OS Pihl, A
Citation: Os. Bruland et A. Pihl, Targeted radiotherapy in the treatment of osteosarcoma - Radiobiological basis, clinical status, and future prospects, RADIOIMMUNOTHERAPY OF CANCER, 2000, pp. 323-337
Internal radionuclide therapy of primary osteosarcoma in dogs, using Sm-153-ethylene-diamino-tetramethylenephosphonate (EDTMP)
Authors: Aas, M Moe, L Gamlem, H Skretting, A Ottesen, N Bruland, OS
Citation: M. Aas et al., Internal radionuclide therapy of primary osteosarcoma in dogs, using Sm-153-ethylene-diamino-tetramethylenephosphonate (EDTMP), CLIN CANC R, 5(10), 1999, pp. 3148S-3152S
Influence of pretreatment with 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (APB) on organ uptake of At-211 and I-125-labeled amidobisphosphonatesin mice
Authors: Murud, KM Larsen, RH Bruland, OS Hoff, P
Citation: Km. Murud et al., Influence of pretreatment with 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (APB) on organ uptake of At-211 and I-125-labeled amidobisphosphonatesin mice, NUCL MED BI, 26(7), 1999, pp. 791-794
Two human osteoblast-like osteosarcoma cell lines show distinct expressionand differential regulation of parathyroid hormone-related protein
Authors: Jemtland, R Rian, E Olstad, OK Haug, E Bruland, OS Bucht, E Gautvik, KM
Citation: R. Jemtland et al., Two human osteoblast-like osteosarcoma cell lines show distinct expressionand differential regulation of parathyroid hormone-related protein, J BONE MIN, 14(6), 1999, pp. 904-914
Complement-mediated lysis of cultured osteosarcoma cell lines using chimeric mouse/human TP-1 IgG1 and IgG3 antibodies
Authors: Olafsen, T Lund, CKM Bruland, OS Sandlie, I Michaelsen, TE
Citation: T. Olafsen et al., Complement-mediated lysis of cultured osteosarcoma cell lines using chimeric mouse/human TP-1 IgG1 and IgG3 antibodies, CANCER IMMU, 48(7), 1999, pp. 411-418
At-211- and I-131-labeled bisphosphonates with high in vivo stability and bone accumulation
Authors: Larsen, RH Murad, KM Akabani, G Hoff, P Bruland, OS Zalutsky, MR
Citation: Rh. Larsen et al., At-211- and I-131-labeled bisphosphonates with high in vivo stability and bone accumulation, J NUCL MED, 40(7), 1999, pp. 1197-1203
Expression of a novel factor in human breast cancer cells with metastatic potential
Authors: Ree, AH Tvermyr, M Engebraaten, O Rooman, M Rosok, O Hovig, E Meza-Zepeda, LA Bruland, OS Fodstad, O
Citation: Ah. Ree et al., Expression of a novel factor in human breast cancer cells with metastatic potential, CANCER RES, 59(18), 1999, pp. 4675-4680
Radiotherapy in Scandinavia
Authors: Olsen, DR Bruland, OS
Citation: Dr. Olsen et Os. Bruland, Radiotherapy in Scandinavia, ACTA ONCOL, 37(6), 1998, pp. 553-560
Risultati: 1-17 |